The changing landscape of drug therapy demands a rethinking of established approaches. Present research is shifting focus towards tailored treatment plans, combining genomics, proteomics, and other advanced biomarkers to anticipate individual response and reduce adverse effects. This emerging paradigm emphasizes precise interventions, aiming for… Read More